Literature DB >> 1535827

IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc.

H Shibuya1, M Yoneyama, J Ninomiya-Tsuji, K Matsumoto, T Taniguchi.   

Abstract

Stimulation via cytokine receptors such as IL-2 and IL-3 receptors, but not by the EGF receptor (EGFR), induces cells of the BAF-B03 hematopoietic cell line to transit the cell cycle. We demonstrate that the IL-2 receptor beta chain (IL-2R beta) is linked to at least two intracellular signaling pathways. One pathway may involve a protein tyrosine kinase of the src family, which leads to the induction of the c-jun and c-fos genes, among others. A second pathway, involving an as yet unknown mechanism, leads to c-myc gene induction. Stimulation of the EGFR, expressed following transfection of an appropriate recombinant construct, can activate the former, but not the latter, pathway in this cell line and cause the cells to enter S phase but not progress further. This deficiency can be rescued by ectopic expression of the c-myc gene, indicating a novel role for this proto-oncogene in the S to G2/M transition of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1535827     DOI: 10.1016/0092-8674(92)90533-i

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  68 in total

1.  The transactivation potential of a c-Myc N-terminal region (residues 92-143) is regulated by growth factor/Ras signaling.

Authors:  M S Colman; M C Ostrowski
Journal:  Nucleic Acids Res       Date:  1996-05-15       Impact factor: 16.971

2.  An alternative pathway for gene regulation by Myc.

Authors:  K Peukert; P Staller; A Schneider; G Carmichael; F Hänel; M Eilers
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

3.  A critical role for cyclin C in promotion of the hematopoietic cell cycle by cooperation with c-Myc.

Authors:  Z J Liu; T Ueda; T Miyazaki; N Tanaka; S Mine; Y Tanaka; T Taniguchi; H Yamamura; Y Minami
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

4.  Hierarchy of protein tyrosine kinases in interleukin-2 (IL-2) signaling: activation of syk depends on Jak3; however, neither Syk nor Lck is required for IL-2-mediated STAT activation.

Authors:  Y J Zhou; K S Magnuson; T P Cheng; M Gadina; D M Frucht; J Galon; F Candotti; R L Geahlen; P S Changelian; J J O'Shea
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

Review 5.  Immunobiology and immunopharmacology of organ allograft rejection.

Authors:  M Suthanthiran; T B Strom
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

6.  Inhibition of cell proliferation by the Mad1 transcriptional repressor.

Authors:  M F Roussel; R A Ashmun; C J Sherr; R N Eisenman; D E Ayer
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

7.  Reconstitution of functional interleukin 2 receptor complexes on fibroblastoid cells: involvement of the cytoplasmic domain of the gamma chain in two distinct signaling pathways.

Authors:  H Asao; T Takeshita; N Ishii; S Kumaki; M Nakamura; K Sugamura
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

8.  Evidence for a critical role for the cytoplasmic region of the interleukin 2 (IL-2) receptor gamma chain in IL-2, IL-4, and IL-7 signalling.

Authors:  A Kawahara; Y Minami; T Taniguchi
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

9.  Interleukin 2 signaling involves the phosphorylation of Stat proteins.

Authors:  D A Frank; M J Robertson; A Bonni; J Ritz; M E Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

10.  Functional coupling of the src-family protein tyrosine kinases p59fyn and p53/56lyn with the interleukin 2 receptor: implications for redundancy and pleiotropism in cytokine signal transduction.

Authors:  N Kobayashi; T Kono; M Hatakeyama; Y Minami; T Miyazaki; R M Perlmutter; T Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.